These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 26211517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urinary osteoprotegerin: a potential biomarker of lupus nephritis disease activity.
    Gupta R, Aggarwal A, Sinha S, Rajasekhar L, Yadav A, Gaur P, Misra R, Negi VS.
    Lupus; 2016 Oct; 25(11):1230-6. PubMed ID: 26936893
    [Abstract] [Full Text] [Related]

  • 4. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.
    Go DJ, Lee JY, Kang MJ, Lee EY, Lee EB, Yi EC, Song YW.
    Lupus; 2018 Sep; 27(10):1600-1615. PubMed ID: 29958502
    [Abstract] [Full Text] [Related]

  • 5. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
    Burcsár S, Toldi G, Kovács L, Szalay B, Vásárhelyi B, Balog A.
    Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
    [Abstract] [Full Text] [Related]

  • 6. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
    Turnier JL, Fall N, Thornton S, Witte D, Bennett MR, Appenzeller S, Klein-Gitelman MS, Grom AA, Brunner HI.
    Arthritis Res Ther; 2017 Oct 24; 19(1):242. PubMed ID: 29065913
    [Abstract] [Full Text] [Related]

  • 7. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis.
    Suzuki M, Wiers K, Brooks EB, Greis KD, Haines K, Klein-Gitelman MS, Olson J, Onel K, O'Neil KM, Silverman ED, Tucker L, Ying J, Devarajan P, Brunner HI.
    Pediatr Res; 2009 May 24; 65(5):530-6. PubMed ID: 19218887
    [Abstract] [Full Text] [Related]

  • 8. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
    Smith EM, Jorgensen AL, Midgley A, Oni L, Goilav B, Putterman C, Wahezi D, Rubinstein T, Ekdawy D, Corkhill R, Jones CA, Marks SD, Newland P, Pilkington C, Tullus K, Beresford MW.
    Pediatr Nephrol; 2017 Feb 24; 32(2):283-295. PubMed ID: 27590021
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
    Abujam B, Cheekatla S, Aggarwal A.
    Lupus; 2013 May 24; 22(6):614-23. PubMed ID: 23629827
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.
    Davies JC, Carlsson E, Midgley A, Smith EMD, Bruce IN, Beresford MW, Hedrich CM, BILAG-BR and MRC MASTERPLANS Consortia.
    Rheumatology (Oxford); 2021 Aug 02; 60(8):3747-3759. PubMed ID: 33313921
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
    Brunner HI, Mueller M, Rutherford C, Passo MH, Witte D, Grom A, Mishra J, Devarajan P.
    Arthritis Rheum; 2006 Aug 02; 54(8):2577-84. PubMed ID: 16868980
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.